X4P-001 and Pembrolizumab in Patients With Advanced Melanoma
Clinical trial NCT02823405 · COMPLETED
Trial details
- NCT number
- NCT02823405
- Sponsor
- X4 Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-15
- Primary completion
- 2018-03-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.